Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company") today reported positive early pilot performance data for ViraxImmune™, its blood-based test in development for Long COVID, myalgic ...
The drug showed promising results in an international study involving nearly 2,400 participants, and the U.S. Food and Drug ...
Add Yahoo as a preferred source to see more of our stories on Google. an iHealth COVID-19 antigen rapid test kit The federal government may destroy its remaining supply of COVID-19 tests. The US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results